Xiamen, China

Guoliang Zhou

This inventor holds 1 USPTO granted patent. Top assignees: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., Xiamen University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guoliang Zhou. Retrieved from https://idiyas.com/inventor/guoliang-zhou-llws0fzp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guoliang Zhou: Innovator in Coronavirus Detection

Introduction

Guoliang Zhou is a notable inventor based in Xiamen, China. He has made significant contributions to the field of biological detection, particularly in relation to the 2019 novel coronavirus. His work has implications for public health and safety.

Latest Patents

Zhou holds a patent titled "Antigen for 2019 Novel Coronavirus and Detection Use Thereof." This patent represents a crucial advancement in the detection of the virus, which has impacted global health.

Career Highlights

Throughout his career, Guoliang Zhou has worked with prominent organizations, including Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. and Xiamen University. His experience in these institutions has allowed him to develop innovative solutions in the field of biological sciences.

Collaborations

Zhou has collaborated with various professionals, including Qiaoyun Shi, to enhance his research and development efforts. These partnerships have contributed to the advancement of his work and the effectiveness of his inventions.

Conclusion

Guoliang Zhou's contributions to the field of coronavirus detection exemplify the importance of innovation in addressing global health challenges. His work continues to influence the scientific community and improve detection methods for infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…